Elray Resources announced a significant milestone in the company’s growth strategy. Elray has completed the sale of proprietary technology to 180 Life Sciences (ATNF) Corp. in exchange for preferred stock convertible into a 40% stake in ATNF and warrants to purchase 3 million shares of ATNF common stock, the conversion/exercise of which is subject to stockholder approval. The technology stack contained within Elray’s technology package will assist ATNF in launching an iGaming Blockchain casino.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATNF:
- 180 Life says ‘uniquely positioned’ to act as consolidator in gaming industry
- 180 Life Sciences regains compliance with Nasdaq listing rule
- 180 Life Sciences shifts focus, enters global iGaming market
- 180 Life Sciences believes acquisition enables continued Nasdaq listing
- 180 Life Sciences reports study results on CBD pill formulation